1.
Greco F, Piacentini P, Remo A, Bonetti A, Ferrandina G. Case 2 – Trabectedin as a maintenance therapy in a patient with recurrent ovarian cancer and BRCA1 germline mutation:  . CBN [Internet]. 2016 Mar. 15 [cited 2024 Nov. 23];4(1):41-4. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/204